Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Astaxanthin

SKU: orb1225008

Description

Astaxanthin is a natural dietary component. Natural astaxanthin is generally recognized as safe (GRAS) by the FDA(In Vitro):Astaxanthin (50, 100, 150, 200 μM; 48 h) inhibits the proliferation of DU145 cells (IC50<200 μM).Astaxanthin (200 μM; 24 h) reduces the expression of STAT3 and the related pathway proteins (at both protein and mRNA levels) by inhibiting proliferation, increasing apoptosis and weakening migration and invasionAstaxanthin protects RPE cells from abnormal activation and oxidative stress (induced by high glucose) by down-regulating VEGF in high glucose at protein levels.Astaxanthin (1-50 μM; 72 h) upregulates protein expression of PPARγ in time- and dose-dependent manners in K562 cells.(In Vivo):Astaxanthin (200 mg/kg; intragastric administration; once daily for 3 weeks) inhibits the growth of DU145 tumor xenografts in nude mice.Astaxanthin (125 or 500 mg/kg; in animal feedings; 7 days) provides significant cardioprotection and reduces oxidative stress in rats.

Images & Validation

Key Properties

CAS Number472-61-7
MW596.84
Purity>98% (HPLC)
FormulaC40H52O4
SMILESO=C1C(C)=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C([C@@H](O)CC2(C)C)=O)C(C)(C)C[C@@H]1O
TargetOthers
SolubilitySoluble in Chloroform

Bioactivity

In Vivo
Astaxanthin (200 mg/kg; intragastric administration; once daily for 3 weeks) inhibits the growth of DU145 tumor xenografts in nude mice. Astaxanthin (125 or 500 mg/kg; in animal feedings; 7 days) provides significant cardioprotection and reduces oxidative stress in rats. Animal model: Nude mice (approximately 20 g; DU145 tumor xenografts model). Dosage: 200 mg/kg. Administration: Intragastric administration; once daily for 3 weeks. Result: Exerted a significant inhibitory effect on tumor growth. Animal model: Female C57BL/6 mice (7 weeks old). Dosage: 125 or 500 mg/kg. Administration: In animal feedings; 7 days. Result: Significantly reduced mean infarct size in the two treated groups (125 and 500 mg/kg) to 45.1% and 39.1%, respectively. Exhibited myocardial salvage of 26 and 36% for 125 and 500 mg/kg groups, respectively. Significantl reduced level of 9-HETE in a dose-dependent manner. 9-HETE is a regioisomer oxidation product of arachidonic acid believed to be a product of free radical-mediated oxidation.
In Vitro
Astaxanthin (50, 100, 150, 200 μM; 48 h) inhibits the proliferation of DU145 cells (IC50<200 μM). Astaxanthin (200 μM; 24 h) reduces the expression of STAT3 and the related pathway proteins (at both protein and mRNA levels) by inhibiting proliferation, increasing apoptosis and weakening migration and invasionAstaxanthin protects RPE cells from abnormal activation and oxidative stress (induced by high glucose) by down-regulating VEGF in high glucose at protein levels. Astaxanthin (1-50 μM; 72 h) upregulates protein expression of PPARγ in time- and dose-dependent manners in K562 cells. Apoptosis Analysis Cell line: DU145 cells. Concentration: 200 μM (pre-incubation). Incubation time: 24 h. Result: Increased the percentage of apoptotic cells from 8.5% to 13.1% (compared to blank control). Cell Migration Assay Cell line: DU145 cells. Concentration: 200 μM. Incubation time: 24 h. Result: Decreased the migration and invasion of DU145 cells (about 41% of cells could not pass from one chamber to another, and 36% cells could not pass through the transwell membrane as compared to the control group). Cell Proliferation Assay Cell line: ARPE-19 cells. Concentration: 50 μM (pre-incubation). Incubation time: 7 days. Result: Significantly decreased cell proliferation exposed to high glucose. Western blot analysis. Cell line: DU145 cells. Concentration: 200 μM. Incubation time: 24 h. Result: Reduced the expression of STAT3 at both protein and mRNA levels (downregulated the protein expression of JAK2, BCL-2 and NF-κB and upregulated the protein expression of BAX, Caspase3 and Caspase9). Western blot analysis. Cell line: K562 cells. Concentration: 1-50 μM. Incubation time: 72 h. Result: Significantly promoted PPARγ protein expression in time- and dose-dependent manners.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

AstaREAL | AstaXin | BioAstin | Carophyll Pink | Lucantin Pink | NatuRose | Ovoester

Similar Products

  • Astaxanthin [orb1304500]

    99.79% (May vary between batches)

    472-61-7

    596.84

    C40H52O4

    20 mg
  • (rac./meso)-Astaxanthin [orb2695126]

    7542-45-2

    596.84

    C40H52O4

    5 mg, 25 mg
  • Astaxanthin dipalmitate [orb3135254]

    112421-21-3

    1073.66

    C72H112O6

    10 mg, 50 mg
  • Astaxanthin monopalmitate [orb3135353]

    123159-02-4

    835.25

    C56H82O5

    50 mg, 10 mg
  • Astacene [orb3141695]

    514-76-1

    592.81

    C40H48O4

    10 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Protocol Information

Available Sizes

Select a size below

100 mg
500 mg
200 mg
2 mg
$ 60.00
5 mg
$ 80.00
10 mg
$ 110.00
25 mg
$ 160.00
50 mg
$ 210.00